Lv5
805 积分 2022-04-19 加入
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
1天前
待确认
Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLC
2天前
已完结
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
2天前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
2天前
已完结
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
3天前
已完结
Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database
3天前
已完结
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper
3天前
已完结
First-line treatment for advanced NSCLC in older patients and those with poor performance status
3天前
已完结
Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs
4天前
已完结
Immunosenescence and immunotherapy in older NSCLC patients
4天前
已完结
皖公网安备34019202002308
